Soligenix
SNGX
#10233
Rank
ยฃ9.35 M
Marketcap
ยฃ0.93
Share price
-1.60%
Change (1 day)
-48.94%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -ยฃ9.46 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ7 Million a decrease over its 2023 earnings that were of -ยฃ5.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ9.46 Million35.13%
2024 -ยฃ7 Million22.96%
2023 -ยฃ5.69 Million-45.74%
2022 -ยฃ10.49 Million11.88%
2021 -ยฃ9.38 Million-32.37%
2020 -ยฃ13.86 Million83.18%
2019 -ยฃ7.57 Million11.57%
2018 -ยฃ6.78 Million19.29%
2017 -ยฃ5.69 Million33%
2016 -ยฃ4.28 Million-19.7%
2015 -ยฃ5.33 Million5.16%
2014 -ยฃ5.07 Million
2010 -ยฃ5.72 Million26.12%
2009 -ยฃ4.53 Million75.1%
2008 -ยฃ2.59 Million-45.38%
2007 -ยฃ4.74 Million-22.84%
2006 -ยฃ6.14 Million66.15%
2005 -ยฃ3.7 Million-16.65%
2004 -ยฃ4.44 Million13.28%
2003 -ยฃ3.92 Million-11.88%
2002 -ยฃ4.44 Million-59.44%
2001 -ยฃ10.95 Million378.18%
2000 -ยฃ2.29 Million-38.53%
1999 -ยฃ3.73 Million-18.43%
1998 -ยฃ4.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ24.24 B-262,014.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ8.87 B-95,920.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ6.81 B-73,673.72%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-ยฃ13.59 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ31.26 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.61 B-17,498.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-ยฃ2.07 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.12 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA